Cargando...
Booster dose vaccination for preventing hepatitis B
BACKGROUND: Antibodies against hepatitis B surface antigen (HBsAg) wane over time following hepatitis B immunisation; hence, it is unclear whether people vaccinated in three‐dose or four‐dose schedules of the hepatitis B vaccine are still immune when the hepatitis B surface antibody (anti‐HBs) level...
Gardado en:
| Publicado en: | Cochrane Database Syst Rev |
|---|---|
| Main Authors: | , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
John Wiley & Sons, Ltd
2016
|
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7154826/ https://ncbi.nlm.nih.gov/pubmed/27271960 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/14651858.CD008256.pub3 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|